Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Small Molecules
Filter     Order     Display # 
Date Item Title
17 Jul 2008 ASA404 programme to expand with new pivotal trial in lung cancer
17 Jul 2008 FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia
17 Jul 2008 Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Disease
17 Jul 2008 Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
17 Jul 2008 Repros Therapeutics Inc. Announces That Proellex(R) Administered to Patients as Cyclic Therapy to Treat the Symptoms of Uterine Fibroids for Up to 30 Months Shows No Adverse Effects on the Endometrium
17 Jul 2008 Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
17 Jul 2008 EpiCept and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia
17 Jul 2008 Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
17 Jul 2008 Astellas Receives a Japanese Marketing Approval for the Immunosuppressant Graceptor(R)
17 Jul 2008 Astellas Receives a Japanese Marketing Approval for Irribow(R)
16 Jul 2008 The BRAVO trial, together with the ongoing ALLEGRO trial will investigate oral laquinimod in more than 2,000 RRMS patients worldwide
16 Jul 2008 BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer, following advice from the Drug Safety Monitoring Board and the Steering Committee
16 Jul 2008 Hollis-Eden Pharmaceuticals Commences Phase II Clinical Trial with TRIOLEX(TM) (HE3286) in Type-2 Diabetes Patients; Expands Sites to Accelerate Enrollment
15 Jul 2008 Infinity Provides Update On Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer
15 Jul 2008 Glenmark’s molecule for Neuropathic Pain, Osteoarthritis - GRC 10693, to enter Phase I trials - GRC 10693 is Glenmark’s fifth molecule to enter clinical trials
15 Jul 2008 MediGene Publishes Update on RhuDex(R) Incident
15 Jul 2008 OSI Pharmaceuticals Begins Clinical Development Program for OSI-027 in Patients with Advanced Solid Tumors or Lymphoma
15 Jul 2008 Rib-X Pharmaceuticals, Inc. Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
15 Jul 2008 Theravance Announces Clinical Results in the LAMA Respiratory Program for the Treatment of COPD
15 Jul 2008 Theravance Announces Positive Phase 2 Clinical Results in the MABA Respiratory Program for the Treatment of COPD
15 Jul 2008 EyeGate Pharma Initiates Landmark Clinical Study Employing the EyeGate(R) II Non-Invasive Ocular Delivery System in Acute Anterior Uveitis
15 Jul 2008 MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
14 Jul 2008 GlaxoSmithKline and Actelion enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond
14 Jul 2008 Penwest Begins Phase Ia Clinical Trial of A0001, a Compound For Treatment of Mitochondrial Diseases
14 Jul 2008 Neurogen Announces Suspension of Insomnia Study with Adipiplon
14 Jul 2008 Cardiome Announces Positive Phase 2b Results for Oral Vernakalant
14 Jul 2008 DiaMedica Meets Primary Endpoint from Phase II DM-83 Study in Type 2 Diabetes
14 Jul 2008 Alkermes Presents Positive Preclinical Data on Naltrexone for Extended-Release Injectable Suspension at Annual Meeting of Controlled Release Society
14 Jul 2008 Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
13 Jul 2008 Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial in Women with Moderate to Severe Endometriosis
13 Jul 2008 Merck Sharp & Dohme (MRK) TREDAPTIVE(TM) Approved in the European Union: New Lipid-Modifying Therapy to Treat LDL-C, HDL-C and Triglycerides
13 Jul 2008 CV Therapeutics Receives European Marketing Authorization for Ranolazine for the Treatment of Patients With Chronic Angina
13 Jul 2008 Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
13 Jul 2008 NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
10 Jul 2008 Oxygen Biotherapeutics Provides Update on Recent Events and Phase IIb Oxycyte Clinical Trial
10 Jul 2008 ValiRx Plc Acquires Global Rights to Novel Compound Targeted at Prostate Cancer
10 Jul 2008 Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD)
10 Jul 2008 Penwest Begins Phase I Clinical Trial of PW 4153, Candidate For Treatment of Symptoms of Parkinson's Disease
10 Jul 2008 BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10 Jul 2008 Sosei Announces Completion of Phase III Trial for NorLevo(R)
10 Jul 2008 Calistoga Pharmaceuticals Initiates First Oncology Clinical Trial Of Novel PI3K Delta Inhibitor, CAL-101
09 Jul 2008 Welichem succesfully completes Phase I clinical trial
09 Jul 2008 Polyphor successfully completes Phase I clinical trials of POL6326
09 Jul 2008 Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
09 Jul 2008 Icagen Successfully Completes Phase I Multiple Ascending Dose Clinical Trial of Senicapoc
09 Jul 2008 Fresenius Medical Care Signs Agreements for Intravenous Iron Products
09 Jul 2008 Paion Announces Plan to Commence Clinical Program with its Sedative CNS 7056
09 Jul 2008 Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
09 Jul 2008 Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
08 Jul 2008 MediGene puts clinical phase I study with RhuDex(R) on hold
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 151 - 200 of 5215

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics